We tested the effect of time since the last semaglutide injection on computational parameters using paired sample t-tests, comparing testing sessions one and six days after the last semaglutide injection
It was spring 2002, and the Danish researcher had spent nearly a decade crafting small molecules in Novo Nordisks laboratories
Thank you to our sponsors AG1 (Athletic Greens): InsideTracker: Thesis: Supplements from Momentous For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Mood Disorders & Maintaining Mental Health (Protocol 1) (00:07:10) Sponsors (00:11:15) Major Depression (00:18:40) Anti-Self Confabulation (00:21:42) Autonomic (Vegetative) Symptoms of Depression (00:26:58) Norepinephrine, Dopamine & Serotonin (00:31:50) SSRIs (Prozac, Zoloft, etc.): Selective Serotonin Reuptake Inhibitors (00:37:00) Epinephrine/Motor Functions, Dopamine/Motivation & Craving, Serotonin/Emotions (00:39:33) Physical & Emotional Pain are Linked: Substance P (00:41:50) Hormones & Depression: Thyroid & Cortisol (00:46:50) Genetic Susceptibility to Depression: Impact of Stress (00:50:50) Understanding Biological Mechanism Is Key: Recipes versus Skills (00:52:50) Tools for Dealing with Depression: Logic & Implementation (Protocol 2) (00:56:25) Brain Inflammation & Mental State: Cytokines, Prostaglandins, etc
How Tirzepatide Works GLP-1 and GIP hormones tell the brain to stop eating
SUSTAIN Trial: Cardiovascular Outcomes in Patients with Type 2 Diabetes The SUSTAIN-6 trial studied semaglutide in people with type 2 diabetes who were at high risk for heart disease
